Skip to main content
Aurobindo Pharma Limited (NSE:AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,154.00
-3.60 (-0.31%)
May 9, 2025, 10:30 AM IST

Aurobindo Pharma Revenue

Aurobindo Pharma had revenue of 79.79B INR in the quarter ending December 31, 2024, with 8.53% growth. This brings the company's revenue in the last twelve months to 309.22B, up 10.85% year-over-year. In the fiscal year ending March 31, 2024, Aurobindo Pharma had annual revenue of 290.02B with 16.68% growth.

Revenue (ttm)
309.22B
Revenue Growth
+10.85%
P/S Ratio
2.17
Revenue / Employee
11.89M
Employees
26,015
Market Cap
672.34B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024290.02B41.46B16.68%
Mar 31, 2023248.55B14.00B5.97%
Mar 31, 2022234.55B-13.19B-5.32%
Mar 31, 2021247.75B16.76B7.26%
Mar 31, 2020230.99B35.35B18.07%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 516.03B
Divi's Laboratories 90.78B
Cipla 267.20B
Apollo Hospitals Enterprise 211.46B
Mankind Pharma 116.41B
Zydus Lifesciences 222.47B
Alkem Laboratories 127.57B
Fortis Healthcare 75.61B
Revenue Rankings

Aurobindo Pharma News

More News